Ka Lai Yee

8PUBLICATIONS
9CO-AUTHORS
PharmacogenomicsInfant and child healthGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 13, 2024
Dealing With Variable Drug Exposure Due to Variable Hepatic Metabolism: A Proof-of-Concept Application of Liquid Biopsy in Renal Impairment.

Amin Rostami-Hodjegan, Zubida M Al-Majdoub, Yannick von Grabowiecki

|Aug 23, 2022
Predicting effectiveness of the V114 vaccine against invasive pneumococcal disease in children.

Josiah Ryman, Jessica Weaver, Ka Lai Yee

|Sep 29, 2020
Physiologically Based Pharmacokinetic Modeling of Doravirine and Its Major Metabolite to Support Dose Adjustment With Rifabutin.

Ka Lai Yee, Tamara D Cabalu, Yuhsin Kuo

|Feb 13, 2020
A time-to-event analysis of the exposure-response relationship for bezlotoxumab concentrations and CDI recurrence.

Ka Lai Yee, Huub Jan Kleijn, Stefan Zajic

|Mar 01, 2019
A Study to Evaluate Doravirine Pharmacokinetics When Coadministered With Acid-Reducing Agents.

Sauzanne G Khalilieh, Ka Lai Yee, Rosa I Sanchez

Pageof 2